Background Interstitial lung disease (ILD) is an important cause of morbidity and mortality in
patients with scleroderma (Scl). Risk prediction and prognostication in patients with Scl-ILD …

Purpose The gender, age, and lung physiology (GAP) model, interstitial lung diseases—
GAP (ILD-GAP) model, and the smoking history, age, and diffusion capacity of the lung …

BACKGROUND Interstitial lung disease (ILD) is the leading cause of morbidity and mortality
in patients with systemic sclerosis (SSc); however, prognostication of SSc-associated ILD …

BACKGROUND Mortality risk prediction tools have been developed in idiopathic pulmonary
fibrosis, however, it is unknown whether these models accurately estimate mortality in …

Background Radiographic end points commonly are included in therapeutic trials for
systemic sclerosis (SSc)-interstitial lung disease (ILD); however, the relationship between …

Objective Although interstitial lung disease (ILD) is a major cause of morbidity and mortality
in systemic sclerosis (SSc), its prognostication remains challenging. Given that CT …

Introduction Interstitial lung disease (ILD) is currently the primary cause of death in systemic
sclerosis (SSc). Thoracic high-resolution computed tomography (HRCT) is considered the …

Objectives To identify the predictive clinical characteristics and establish a prediction model
for the progression of mild interstitial lung disease (ILD) in patients with systemic sclerosis …

Objective To assess survival and identify predictors of survival in patients with systemic
sclerosis-interstitial lung disease (SSc-ILD) who participated in the Scleroderma Lung …

Background Risk prediction is challenging in chronic interstitial lung disease (ILD) because
of heterogeneity in disease-specific and patient-specific variables. Our objective was to …